Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Simplex Type II”

57 trials

Showing 20 of 57 results

Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Not applicableStudy completedNCT03701802
What this trial is testing

Immunogenetic Modulators of Mucosal Protection From HIV-1

Who this might be right for
HIV InfectionsHSV-2 Infection
University of Washington 812
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableWithdrawnNCT00682721
What this trial is testing

Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

Who this might be right for
Bacterial VaginosisHerpes Simplex Virus Type II
University of Pittsburgh
Large-scale testing (Phase 3)Study completedNCT00860977
What this trial is testing

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Who this might be right for
HIV InfectionHerpes Simplex Type IIHIV Infections
University Health Network, Toronto 202
Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Not applicableStudy completedNCT04205721
What this trial is testing

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

Who this might be right for
HSV-2 InfectionHIV InfectionsPregnancy Related
University of North Carolina, Chapel Hill 23,061
Not applicableStudy completedNCT03868644
What this trial is testing

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

Who this might be right for
HIV/AIDSHSV-2 Infection
Abdul Latif Jameel Poverty Action Lab 10,646
Not applicableStudy completedNCT03080961
What this trial is testing

The VIBLOK SAfety and perFormancE Trial

Who this might be right for
HSV-2 InfectionGenital Herpes
CLJI Worldwide 82
Testing effectiveness (Phase 2)Looking for participantsNCT03866525
What this trial is testing

OH2 Oncolytic Viral Therapy in Solid Tumors

Who this might be right for
Solid TumorGastrointestinal Cancer
Binhui Biopharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT06033261
What this trial is testing

MRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Who this might be right for
Genital Herpes
ModernaTX, Inc. 365
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07308886
What this trial is testing

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 55
Post-approval studies (Phase 4)Study completedNCT00362297
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 31
Not applicableEnded earlyNCT00138320
What this trial is testing

Herpevac Neonatal Substudy

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Looking for participantsNCT04386967
What this trial is testing

OH2 Injection in Solid Tumors

Who this might be right for
Solid TumorMelanoma
Binhui Biopharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT04637698
What this trial is testing

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Binhui Biopharmaceutical Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation